Phase IV Study on the Effects of Onabotulinumtoxina Intradetrusorial Injections on Bladder Expression of NGF, TRKA. P75 and TRPV1 in Patients with Detrusor Overactivity.

Trial Profile

Phase IV Study on the Effects of Onabotulinumtoxina Intradetrusorial Injections on Bladder Expression of NGF, TRKA. P75 and TRPV1 in Patients with Detrusor Overactivity.

Completed
Phase of Trial: Phase IV

Latest Information Update: 03 Jul 2012

At a glance

  • Drugs Botulinum toxin A (Primary)
  • Indications Overactive bladder
  • Focus Biomarker; Pharmacodynamics
  • Most Recent Events

    • 03 Jul 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top